Version 3 of the national Alzheimer's coordinating center's uniform data set

Lilah Besser*, Walter Kukull, David S. Knopman, Helena Chui, Douglas Galasko, Sandra Weintraub, Gregory Jicha, Cynthia Carlsson, Jeffrey Burns, Joseph Quinn, Robert A. Sweet, Katya Rascovsky, Merilee Teylan, Duane Beekly, George Thomas, Mark Bollenbeck, Sarah Monsell, Charles Mock, Xiao Hua Zhou, Nicole ThomasElizabeth Robichaud, Margaret Dean, Janene Hubbard, Mary Jacka, Kristen Schwabe-Fry, Joylee Wu, Creighton Phelps, John C. Morris

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

295 Scopus citations

Abstract

Introduction: In 2015, the US Alzheimer's Disease Centers (ADC) implemented Version 3 of the Uniform Data Set (UDS). This paper describes the history of Version 3 development and the UDS data that are freely available to researchers. Methods: UDS Version 3 was developed after years of coordination between the National Institute on Aging-appointed Clinical Task Force (CTF), clinicians from ∼30 ADCs, and the National Alzheimer's Coordinating Center (NACC). The CTF recognized the need for updates to align with the state of the science in dementia research, while being flexible to the diverse needs and diseases studied at the ADCs. Version 3 also developed a nonproprietary neuropsychological battery. Results: This paper focuses on the substantial Version 3 changes to the UDS forms related to clinical diagnosis and characterization of clinical symptoms to match updated consensus-based diagnostic criteria. Between March 2015 and March 2018, 4820 participants were enrolled using UDS Version 3. Longitudinal data were available for 25,337 of the 37,568 total participants using all UDS versions. Discussion: The results from utilization of the UDS highlight the possibility for numerous research institutions to successfully collaborate, produce, and use standardized data collection instruments for over a decade.

Original languageEnglish (US)
Pages (from-to)351-358
Number of pages8
JournalAlzheimer Disease and Associated Disorders
Volume32
Issue number4
DOIs
StatePublished - 2018

Funding

Supported by NIA/NIH Grant U01 AG016976 (W.K.). Supported by the NIH (P50 AG16574) (D.S.K.). Supported by NIA grant AG05131(D.G.). Supported by NIH/NIA P30 AG028383 (G.J.). Research supported from the National Institutes of Health (P50AG033514, R01AG027161, R01AG011099, U19AG010483, R01AG049872, UF1AG051216, R01AG021155, R56AG037639, U2CAG057441, R01AG052324), the Department of Veterans Affairs (CSR&D I01 CX001261), the RECALL Foundation, the Alzheimer’s Association and Foundation for NIH, Janssen, and Lilly (C.C.). Receives research support from the National Institutes of Health (R01AG058557, R01AG053312, R01AG034614, R01AG03367, R01AG043962, P30AG035982, U10NS077356, UL1TR000001); received research support in the last 2 years for clinical trials from Lilly, Avid Radiopharmaceuticals, Toyama Chemical Company, Merck, Biogen, AbbVie, vTv Therapeutics, and Janssen (J.B.). Supported by NIA AG08017 (J.Q.). Supported by NIA AG 046499 and AG 017586 (K.R.). Receives research support from Eli Lilly/Avid Radiopharmaceuticals and is funded by NIH grants # P50AG005681; P01AG003991; P01AG026276; and UF01AG032438 (J.C.M.). The NACC database is funded by NIA/NIH Grant U01 AG016976. Additional acknowledgements to the Alzheimer’s Disease Centers are provided in Supplemental Digital Content 1 (http://links.lww.com/WAD/A207). The authors thankfully acknowledge all of the faculty and staff at the ADCs, UDS participants and co-participants, as well as the following sites for participating in the pilot study of the Spanish translation of UDS Version 3: University of California, San Diego; University of Southern California; Mount Sinai School of Medicine; Memory Clinic at the Institute on Aging, Pontificia Universidad Javeriana School of Medicine, Bogota, Colombia; Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia, Buenos Aires, Argentina; Instituto Nacional de Neurología y Neuro-cirugía “Manuel Velasco Suárez,” Mexico City, Mexico; Peru Young-Onset Dementia Network: Universidad Peruana Cayetano Heredia and Clínica Internacional. Lima, Peru.

Keywords

  • Alzheimer disease
  • Alzheimer disease center
  • Lewy body disease
  • MCI
  • National Alzheimer's Coordinating Center
  • frontotemporal degeneration

ASJC Scopus subject areas

  • Clinical Psychology
  • Gerontology
  • Geriatrics and Gerontology
  • Psychiatry and Mental health

Fingerprint

Dive into the research topics of 'Version 3 of the national Alzheimer's coordinating center's uniform data set'. Together they form a unique fingerprint.

Cite this